Navigation Links
Single Cancer Stem Cell may Be Sufficient to Initiate and Maintain a Malignant Tumour

Nobel Laureate Dr. Renato Dulbecco has demonstrated that an injection of a single cell taken from cultured LA7 cells into mouse breast tissue can seed a new mammary carcinoma .

The results of the efforts of an international team of researchers led by Dr. Dulbecco, President Emeritus and Distinguished Resident Professor at the Salk Institute for Biological Studies, support the observation that though cancer stem cells are rare, in the bulk of a tumour, a single cancer stem cell is sufficient to initiate and maintain a malignant tumour.

We can use single cancer stem cells to study the dynamics and behaviour of cancer stem cells and their role in solid tumour formation at the single cell level, says lead author Dr. Ileana Zucchi, a molecular cancer biologist at the Institute for Biological Technology (ITB-CNR) in Milan, Italy.

The researchers believe that a model of cancer stem cell system may allow them to identify genes and proteins that will help with the search for human breast cancer stem cells in the future.

As we learn more about tumour formation at the single cell level in tissue, we may be able to specifically target cancer stem cells for destruction while leaving the normal stem cells in the body intact, hopes Zucchi.

The researchers say that it is well known that tumour cells and stem cells share many properties, which is characterised by their abilities to divide and generate both new stem cells and specialized cell types. However, there exists a major difference between the two.

Although normal stem cells show significant stem cell renewal, they are usually not associated with uncontrolled cell proliferation when they reside within their normal environment or niche. Cancer stem cells, however, are not equally responsive to environmental cues that repress uncontrolled cell proliferation of the stem cells, explains Zucchi.

With a view to assessing the LA7 cells tumorigenic potential, the researchers injected them into the breast tissue of female mice. They observed that unable to respond to conditions that prevent normal stem cells from spinning out of control, even a single LA7 cell started to form tumours.

If tumour induction was dependent on injecting more than one cell, it would be difficult to determine whether cells that appear to be resistant to these conditions are simply cell types different from cancer stem cells, Zucchi says.

But since we start with a single cancer stem cell for injection, we know that the resistance must derive from the original cancer stem cell, adds the researcher.


'"/>




Related medicine news :

1. Single gene analysis for diagnosis of a range of blood disorders
2. Single drug for bipolar disorder
3. Treating Testicular Cancer With A Single Dose Of Chemotherapy
4. Decreasing Multiple Births By Single Embryo Transfers
5. Single gene skin cancer cause
6. Drug Firms To Produce Single Pill AIDS Treatment
7. Malaria May Gain Resistance To Single Drug Prescriptions
8. Single Women with Baby Cravings Can Actually Cradle their Own, Courtesy NHS
9. Thai Doctors Removed 421 Kidney Stones From A Single Person
10. Single Dose Of Azithromycin Could Cure Trichiasis
11. Effects Of Certain Food Related To Single Pain Receptors
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/17/2017)... ... January 17, 2017 , ... Metro Development Group has broken ... speed technology into the fabric of an entire community. A highlight of this ... wellness in a yet-to-be-named, health focused campus. Leading this initiative in partnership with ...
(Date:1/17/2017)... , ... January 17, 2017 , ... ... – will lecture to primary eye care practitioners on the latest breakthroughs in ... upcoming 13th Semi-Annual Continuing Education Symposium, according to eye surgeon, Jeffrey Martin, MD, ...
(Date:1/17/2017)... ... January 17, 2017 , ... SC&H Group, a leading ... a Principal in its IT Advisory Services practice . Rossi is the third ... market demand for strategic IT guidance grows, and the practice continues to expand.     , ...
(Date:1/17/2017)... ... 17, 2017 , ... Lynx Technology Partners (Lynx), ... security companies for consecutive years, today announced the appointment of four members to ... nomination process to a close and positions Lynx for even faster growth in ...
(Date:1/16/2017)... ... 17, 2017 , ... Recently, patients and staff from A Forever Recovery, a ... organizations in support of the annual Binder Park Zoo Halloween celebration known as the ... costumes of all designs coming out to enjoy games, face painting, and lots and ...
Breaking Medicine News(10 mins):
(Date:1/17/2017)... Advertising -- Bronstein, Gewirtz & Grossman, LLC is investigating potential ... or the "Company") (NASDAQ: ANTH ). Such investors ... by visiting the firm,s site: www.bgandg.com/anth .   ... and/or directors have violated Sections 10(b) and 20(a) of the ... ...
(Date:1/17/2017)... WASHINGTON , Jan. 17, 2017  In a ... CEO Jo Ann Jenkins outlines AARP,s priorities ... and Social Security, ensuring access to affordable health care ... In the letter Jenkins writes to President-elect Trump ... older Americans are counting on you to protect their ...
(Date:1/17/2017)... 2017 Immune Pharmaceuticals (NASDAQ: IMNP ... that it will hold a Satellite Symposium on February 20th, ... XVI in Munich, Germany . ... of Immunotherapy for the maintenance of remission in AML ... th , 2017 from 12:45 – 13:45 CET in ...
Breaking Medicine Technology: